Board Cancels Claims Of Patent Covering Treatment For Lymphomas

Mealey's (October 5, 2018, 12:11 PM EDT) -- ALEXANDRIA, Va. — In a final written decision issued Oct. 4, the Patent Trial and Appeal Board agreed with an inter partes review (IPR) petitioner that six claims of a patented...
To view the full article, register now.